Uncovering the TETON Phase III Clinical Trial of Inhaled Treprostinil in the Treatment of Idiopathic Pulmonary Fibrosis
Time: 9:10 am
day: Day Two
Details:
- Reviewing the background on inhaled treprostinil development and potential for treatment in IPF
- Exploring key study design and attributes of the TETON phase III clinical program
